Back to Dashboard
RGEN · Healthcare

Repligen Corp

USA Healthcare Filing: 2026-06-30
31/100
Smart-money confidence1 of 3 sources positive
Below average interest

No standout activity across the feeds we track.

What this band has actually done: stocks scoring 25–45 beat the S&P 500 over the next three months 45.3% of the time, across 39,662 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this

Hedge funds
41
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$10.7B
Industry
Medical Instruments & Supplies
Sector
Healthcare
Exchange
NasdaqGS
About REPLIGEN CORP

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It…

Who's behind the signal
Every informed buyer we can see on RGEN, across all three feeds.
Hedge funds · 8
D.E. Shaw & Co New position
Point72 (Steve Cohen) Decreased −71%
+2 more in the full breakdown below ↓
Congress · 3
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 8 on record
Disclosures from 2022-05-05 to 2025-10-31
Trade date Member Chamber Action Amount
2025-10-31 Lisa C. McClain · R-MI House Sold $1,001 - $15,000
2025-10-30 Lisa C. McClain · R-MI House Sold $1,001 - $15,000
2025-10-30 Lisa C. McClain · R-MI House Bought $1,001 - $15,000
2025-07-22 Lisa C. McClain · R-MI House Bought $1,001 - $15,000
2025-06-17 Lisa C. McClain · R-MI House Sold $1,001 - $15,000
2025-06-11 Lisa C. McClain · R-MI House Bought $1,001 - $15,000
2025-04-07 Jefferson Shreve · R-IN House Sold $15,001 - $50,000
2022-05-05 Josh Gottheimer · D-NJ House Bought $1,001 - $15,000
Not a model pick — but on our radar. REPLIGEN CORP isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
3
New positions
2
Increasing
2
Decreasing
1
Unchanged
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to REPLIGEN CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell REPLIGEN CORP or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费,直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订